Furukawa K - Search Results

1

L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.

Oka M, Ochi Y, Furukawa K, Ito T, Miura Y, Karasawa T, Kadokawa T. Oka M, et al. Among authors: furukawa k. Arzneimittelforschung. 1989 Mar;39(3):297-303. Arzneimittelforschung. 1989. PMID: 2547386

2

Memory deficits following internal capsule lesions in rats and their improvement by L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide (RGH-2202), a thyrotropin-releasing hormone analogue.

Oka M, Ito T, Furukawa K, Karasawa T, Kadokawa T. Oka M, et al. Among authors: furukawa k. Arch Int Pharmacodyn Ther. 1990 Jul-Aug;306:18-33. Arch Int Pharmacodyn Ther. 1990. PMID: 1981666

3

General pharmacology of the novel antiepileptic compound zonisamide. 1st communication: effects on central nervous system.

Hori M, Ito T, Oka M, Noda Y, Matsuno Y, Furukawa K, Ochi Y, Karasawa T, Kadokawa T. Hori M, et al. Among authors: furukawa k. Arzneimittelforschung. 1987 Oct;37(10):1124-30. Arzneimittelforschung. 1987. PMID: 3435583

4

AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties.

Yoshida N, Omoya H, Oka M, Furukawa K, Ito T, Karasawa T. Yoshida N, et al. Among authors: furukawa k. Arch Int Pharmacodyn Ther. 1989 Jul-Aug;300:51-67. Arch Int Pharmacodyn Ther. 1989. PMID: 2533479

5

Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.

Oka M, Noda Y, Ochi Y, Furukawa K, Une T, Kurumiya S, Hino K, Karasawa T. Oka M, et al. Among authors: furukawa k. J Pharmacol Exp Ther. 1993 Jan;264(1):158-65. J Pharmacol Exp Ther. 1993. PMID: 8093723

6

Effects of RGH-2202 on behavioral deficits after focal cerebral ischemia in rats.

Noda Y, Furukawa K, Kohayakawa H, Oka M. Noda Y, et al. Among authors: furukawa k. Pharmacol Biochem Behav. 1995 Dec;52(4):695-9. doi: 10.1016/0091-3057(95)00134-i. Pharmacol Biochem Behav. 1995. PMID: 8587907

7

Pharmacological studies of 1-(2,3-dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1- propanone hydrochloride (AD-2239), a centrally acting muscle relaxant.

Ito T, Hori M, Furukawa K, Karasawa T, Kadokawa T. Ito T, et al. Among authors: furukawa k. Arch Int Pharmacodyn Ther. 1985 May;275(1):105-22. Arch Int Pharmacodyn Ther. 1985. PMID: 3839647

8

Functional change in the rat spinal cord by chronic spinal transection and possible roles of monoamine neurons.

Ito T, Furukawa K, Karasawa T, Kadokawa T, Shimizu M. Ito T, et al. Among authors: furukawa k. Jpn J Pharmacol. 1985 Jul;38(3):243-51. doi: 10.1254/jjp.38.243. Jpn J Pharmacol. 1985. PMID: 3877202 Free article.

9

Monoamine metabolites as indicators of the effect of centrally acting drugs on monoamine release in rat brain.

Karasawa T, Furukawa K, Ochi Y, Shimizu M. Karasawa T, et al. Among authors: furukawa k. Arch Int Pharmacodyn Ther. 1978 Feb;231(2):261-73. Arch Int Pharmacodyn Ther. 1978. PMID: 646524 No abstract available.

10

Antidepressant properties of 2-(4-ethyl-1-piperazinyl)-4-phenylquinoline hydrochloride (AD-1308) and its mechanism of action as compared with tricyclic antidepressants.

Karasawa T, Furukawa K, Ochi Y, Ito T, Yoshida K, Shimizu M. Karasawa T, et al. Among authors: furukawa k. Arch Int Pharmacodyn Ther. 1980 Jun;245(2):283-302. Arch Int Pharmacodyn Ther. 1980. PMID: 6773486 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,314 results

Search Page

Filters